In
Antiviral Research
on 1 August 2003
by
Julander, J. G., Colonno, R. J., et al.
Entecavir (ETV), a cyclopentyl guanosine nucleoside analog, was evaluated in transgenic mice expressing hepatitis B virus (HBV). ETV administered orally once daily for 10 days at a dosage of 3.2mg/kg significantly (P
